Global consortium plans coordinated human challenge studies in hunt for transmission-blocking coronavirus vaccines
11th March 2024
An international consortium of researchers specialising in human challenge studies is embarking on a US$57 million project to develop advanced, virus-blocking coronavirus vaccines.